亚胺培南：一种新型碳青霉烯类抗生素。
Imipenem: a new carbapenem antibiotic.
作者信息
Lipman B, Neu H C
机构信息
Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York.
出版信息
Med Clin North Am. 1988 May;72(3):567-79. doi: 10.1016/s0025-7125(16)30759-3.
PMID:3280907
Abstract
Imipenem is a new carbapenem antibiotic that has an extremely broad spectrum of antibacterial activity. It has been used to treat a variety of serious infections and an increasing volume of literature documents its value in infections due to multiresistant bacteria. This article reviews the antibacterial activity, pharmacology, and clinical uses of imipenem.
摘要
亚胺培南是一种新型碳青霉烯类抗生素，具有极广的抗菌谱。它已被用于治疗各种严重感染，越来越多的文献证明了其在多重耐药菌感染中的价值。本文综述了亚胺培南的抗菌活性、药理学及临床应用。
相似文献
1
Imipenem: a new carbapenem antibiotic.亚胺培南：一种新型碳青霉烯类抗生素。
Med Clin North Am. 1988 May;72(3):567-79. doi: 10.1016/s0025-7125(16)30759-3.
2
Imipenem-cilastatin: the first thienamycin antibiotic.亚胺培南-西司他丁：第一种硫霉素类抗生素。
Pediatr Infect Dis. 1986 Jul-Aug;5(4):444-8.
3
Pharmacokinetic and clinical evaluation of imipenem/cilastatin in children and neonates.
Scand J Infect Dis Suppl. 1987;52:40-5.
4
Imipenem/cilastatin: the first carbapenem antibiotic.亚胺培南/西司他丁：第一种碳青霉烯类抗生素。
Drug Intell Clin Pharm. 1985 Dec;19(12):895-9.
5
Primaxin: an antibiotic for (nearly) all bacterial infections.泰能：一种（几乎）适用于所有细菌感染的抗生素。
Nursing. 1987 Mar;17(3):102. doi: 10.1097/00152193-198703000-00033.
6
Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.比较亚胺培南-西司他丁与克林霉素及庆大霉素治疗严重外科感染的前瞻性研究。
Arch Surg. 1988 Mar;123(3):322-6. doi: 10.1001/archsurg.1988.01400270056008.
7
Imipenem-cilastatin sodium (Primaxin).亚胺培南西司他丁钠（泰能）。
Med Lett Drugs Ther. 1986 Mar 14;28(709):29-31.
8
Imipenem/cilastatin.亚胺培南/西司他丁
Eur J Clin Microbiol. 1984 Oct;3(5):453-5. doi: 10.1007/BF02017374.
9
10
A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.亚胺培南/西司他丁与拉氧头孢比较疗效、安全性及耐受性的多中心随机研究
Eur J Clin Microbiol. 1984 Oct;3(5):478-87. doi: 10.1007/BF02017380.
引用本文的文献
1
Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens.塞来昔布增强低剂量抗生素治疗小鼠多微生物败血症及ESKAPE病原体临床分离株的疗效。
Front Microbiol. 2017 May 8;8:805. doi: 10.3389/fmicb.2017.00805. eCollection 2017.
2
Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats.新型1β-甲基碳青霉烯类抗生素LJC 10,627的低神经毒性：与大鼠缺乏中枢神经系统毒性相关的γ-氨基丁酸A、苯二氮䓬和甘氨酸受体结合抑制作用
Antimicrob Agents Chemother. 1993 Feb;37(2):199-202. doi: 10.1128/AAC.37.2.199.
3
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.新型碳青霉烯类药物SM-7338的体外活性及β-内酰胺酶稳定性
Antimicrob Agents Chemother. 1989 Jul;33(7):1009-18. doi: 10.1128/AAC.33.7.1009.
4
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.新型碳青霉烯类药物LJC10,627对脱氢肽酶I稳定的体外及体内活性
Antimicrob Agents Chemother. 1991 Jan;35(1):203-7. doi: 10.1128/AAC.35.1.203.
Zotero 插件